论文部分内容阅读
目的:评价黄葵胶囊与缬沙坦联用治疗慢性肾小球肾炎患者的临床疗效。方法:选取2016年3月—2017年3月间收治的慢性肾小球肾炎患者68例,采用随机分组法将其分为观察组(34例)和对照组(34例);对照组患者给予缬沙坦胶囊治疗,观察组患者在对照组治疗基础上加用黄葵胶囊治疗;评价两组患者治疗8周后的总有效率和治疗前后尿蛋白、血肌酐、血清尿素氮测得值的变化情况。结果:两组患者治疗后上述指标优于治疗前(P<0.05);观察组患者治疗后尿蛋白、血肌酐和血清尿素氮含量测得值低于对照组(P<0.05),总有效率为94.12%明显高于对照组为64.71%(P<0.05)。结论:采用黄葵胶囊与缬沙坦治疗慢性肾小球肾炎患者,能有效
Objective: To evaluate the clinical efficacy of Huang Kui capsule combined with valsartan in the treatment of patients with chronic glomerulonephritis. Methods: Sixty-eight patients with chronic glomerulonephritis admitted from March 2016 to March 2017 were selected and randomly divided into observation group (34 cases) and control group (34 cases). Patients in the control group Valsartan capsule treatment, the observation group patients in the control group based on the use of Huang Kui capsule treatment; evaluation of two groups of patients after 8 weeks of treatment of total effective rate and before and after treatment of urinary protein, serum creatinine, serum urea nitrogen measured values Changes. Results: The above indexes in both groups were better than those before treatment (P <0.05). The urinary protein, serum creatinine and serum urea nitrogen in the observation group were lower than those in the control group after treatment (P <0.05), and the total effective rate 94.12% was significantly higher than the control group was 64.71% (P <0.05). Conclusion: The use of Huang Kui capsule and valsartan in patients with chronic glomerulonephritis, can be effective